Feike Du

Investment Associate

Feike loves working with mission-driven founders who have global ambitions. She’s particularly passionate about women’s health and the future of finance.

Feike joined MMC in 2020. She is a board observer for LiveEO, Apexx, Supercede and Habitual, and is also involved in MMC investments such as Bloom & Wild, Peak, Tyk and Current Health (before its exit).

Before joining MMC she was an investor at Temasek in London and Singapore, where she worked on growth investments ranging from €100m-3bn. Prior to Temasek, she spent two years in investment banking at Credit Suisse advising clients on M&A and capital markets transactions.

Feike graduated cum laude from the Rotterdam School of Management, Erasmus University with an MSc in Finance & Investment. She also studied at the University of St. Gallen in Switzerland and at Shanghai’s Jiaotong University.

Newsletter Sign Up

Sign up for latest news